These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36184742)

  • 1. Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis.
    Radojević D; Bekić M; Gruden-Movsesijan A; Ilić N; Dinić M; Bisenić A; Golić N; Vučević D; Đokić J; Tomić S
    Gut Microbes; 2022; 14(1):2127455. PubMed ID: 36184742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
    Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2018; 9():1782. PubMed ID: 30123217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary Cholangitis.
    Wang R; Li B; Huang B; Li Y; Liu Q; Lyu Z; Chen R; Qian Q; Liang X; Pu X; Wu Y; Chen Y; Miao Q; Wang Q; Lian M; Xiao X; Leung PSC; Gershwin ME; You Z; Ma X; Tang R
    Gastroenterology; 2024 Sep; 167(4):733-749.e3. PubMed ID: 38810839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.
    Stanisavljević S; Dinić M; Jevtić B; Đedović N; Momčilović M; Đokić J; Golić N; Mostarica Stojković M; Miljković Đ
    Front Immunol; 2018; 9():942. PubMed ID: 29770137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis.
    Melero-Jerez C; Alonso-Gómez A; Moñivas E; Lebrón-Galán R; Machín-Díaz I; de Castro F; Clemente D
    Neurobiol Dis; 2020 Jul; 140():104869. PubMed ID: 32278882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model.
    Jiang Q; Duan J; Van Kaer L; Yang G
    Aging Dis; 2024 May; 15(3):1329-1343. PubMed ID: 37307825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.
    Bianchimano P; Britton GJ; Wallach DS; Smith EM; Cox LM; Liu S; Iwanowski K; Weiner HL; Faith JJ; Clemente JC; Tankou SK
    Microbiome; 2022 Oct; 10(1):174. PubMed ID: 36253847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
    Camacho-Toledano C; Machín-Díaz I; Calahorra L; Cabañas-Cotillas M; Otaegui D; Castillo-Triviño T; Villar LM; Costa-Frossard L; Comabella M; Midaglia L; García-Domínguez JM; García-Arocha J; Ortega MC; Clemente D
    J Neuroinflammation; 2022 Nov; 19(1):277. PubMed ID: 36403026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung.
    Glenn JD; Liu C; Whartenby KA
    J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
    Casacuberta-Serra S; Costa C; Eixarch H; Mansilla MJ; López-Estévez S; Martorell L; Parés M; Montalban X; Espejo C; Barquinero J
    Exp Neurol; 2016 Dec; 286():50-60. PubMed ID: 27693617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
    Ortega MC; Lebrón-Galán R; Machín-Díaz I; Naughton M; Pérez-Molina I; García-Arocha J; Garcia-Dominguez JM; Goicoechea-Briceño H; Vila-Del Sol V; Quintanero-Casero V; García-Montero R; Galán V; Calahorra L; Camacho-Toledano C; Martínez-Ginés ML; Fitzgerald DC; Clemente D
    Acta Neuropathol; 2023 Aug; 146(2):263-282. PubMed ID: 37243699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism.
    Han B; Shi L; Bao MY; Yu FL; Zhang Y; Lu XY; Wang Y; Li DX; Lin JC; Jia W; Li X; Zhang Y
    Microbiome; 2024 Jun; 12(1):114. PubMed ID: 38915127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota.
    Lu XY; Han B; Deng X; Deng SY; Zhang YY; Shen PX; Hui T; Chen RH; Li X; Zhang Y
    Gut Microbes; 2020 Nov; 12(1):1857515. PubMed ID: 33382357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of EAE mice with Treg, G-MDSC and IL-2: a new insight into cell therapy for multiple sclerosis.
    Ghorbani MM; Farazmandfar T; Abediankenari S; Hassannia H; Maleki Z; Shahbazi M
    Immunotherapy; 2022 Jul; 14(10):789-798. PubMed ID: 35678041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.
    Yi H; Guo C; Yu X; Zuo D; Wang XY
    J Immunol; 2012 Nov; 189(9):4295-304. PubMed ID: 23034169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis.
    Stanisavljević S; Lukić J; Momčilović M; Miljković M; Jevtić B; Kojić M; Golić N; Mostarica Stojković M; Miljković D
    Benef Microbes; 2016 Jun; 7(3):363-73. PubMed ID: 26839070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
    Melero-Jerez C; Suardíaz M; Lebrón-Galán R; Marín-Bañasco C; Oliver-Martos B; Machín-Díaz I; Fernández Ó; de Castro F; Clemente D
    Neurobiol Dis; 2019 Jul; 127():13-31. PubMed ID: 30798007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Lin X; Liu Y; Ma L; Ma X; Shen L; Ma X; Chen Z; Chen H; Li D; Su Z; Chen X
    J Transl Med; 2021 Jul; 19(1):317. PubMed ID: 34301274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE.
    Tanwar S; Oguz C; Metidji A; Dahlstrom E; Barbian K; Kanakabandi K; Sykora L; Shevach EM
    J Autoimmun; 2020 Dec; 115():102525. PubMed ID: 32709481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.